Phospho-BRCA2 (S3291) Polyclonal Antibody BT-PHS00512
Specifications
| 20ul / 50ul / 100ul |
Background:
Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele.
Classification:
Primary antibody
Alternative names:
BRCA2; FACD; FANCD1; Breast cancer type 2 susceptibility protein; Fanconi anemia group D1 protein
Species reactivity:
Human;mouse;rat
Host:
Rabbit
Isotype:
IgG
Immunogen:
Synthesized phospho-peptide around the phosphorylation site of human BRCA2 (phospho Ser3291)
Concentration:
1 mg/ml
Molecular weight:
384225
Applications:
WB, ELISA
Storage:
-20°C for one year
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
